(266 days)
Not Found
No
The device description details passive electrodes that conduct electrical signals. There is no mention of any computational processing, algorithms, or learning capabilities.
No.
The device description explicitly states that the electrodes are "passive devices serving as an interface between a patient's skin and a neurostimulation device," indicating they facilitate the therapeutic action of another device rather than providing therapy themselves.
No
The 'Intended Use / Indications for Use' states that the electrodes are "passive devices serving as an interface between a patient's skin and a neurostimulation device," which are used for treatment (neurostimulation), not diagnosis.
No
The device description clearly outlines physical components (wire, insulation backing, conductive surface, conductive adhesive gel) and their function in conducting an electrical signal. This indicates a hardware device, not a software-only device.
Based on the provided information, the Lifecare electrodes are not an In Vitro Diagnostic (IVD) device.
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the examination of specimens derived from the human body (such as blood, urine, or tissue) to provide information for diagnostic, monitoring, or compatibility purposes.
- Lifecare Electrodes Function: The description clearly states that these electrodes are "passive devices serving as an interface between a patient's skin and a neurostimulation device." They function by conducting an electrical signal to the patient's skin, not by analyzing a specimen from the patient's body.
- Intended Use: The intended use is with transcutaneous neurostimulation devices (like TENS and EMS) for over-the-counter use. This is a therapeutic or pain management application, not a diagnostic one.
Therefore, the Lifecare electrodes fall under the category of medical devices, but specifically those used for delivering electrical stimulation to the body, not for in vitro diagnostic testing.
N/A
Intended Use / Indications for Use
The Lifecare electrodes are intended for use with transcutaneous neurostimulation devices as over the counter. Some common type of neurostimulation devices include, but are not limited to, TENS devices and EMS devices. Transcutaneous neurostimulation electrodes are passive devices serving as an interface between a patient's skin and a neurostimulation device.
Product codes
GXY
Device Description
The Lifecare electrodes are constructed with four basic components: a wire; an insulation backing, a conductive surface; and a conductive adhesive gel. The devices function by conducting an electrical signal from a neurostimulation device through the wire. The signal is then dispersed from the wire across the conductive surface. Finally the signal is transmitted from the conductive surface through the conductive adhesive gel to the surface of the patient's skin.
Everyway Self Adhesive Electrode, Wire series are non-sterile, disposable laminated, flexible structures composed of material commonly used in this application:
First Laver - White spun laced nonwoven tape or white thick Polyethylene foam or a polypropylene substrate, coated with biocompatible adhesive.
Second Laver - Conductive plastic film
Third Layer – Biocompatible conductive hydrogel coupling media
The electrodes are designed for single-patient/single application use. Because of the adhesive nature of the biocompatible hydrogel, no securing materials are required to secure the device to the patient's skin. The electrode has one type of connection point that can be used to connect the stimulation device the electrodes. This connection point is compatible with standard, marketed Neurostimulation devices.
For the electrical connection, Everyway provides one type of connection:
Wire Series - Lead wire assembly - 4.5" - 6" wire with 0.080 in. diameter female socket connected to one side of the wire.
These electrodes are: TKF5050 (5x5 cm square), TKF4040 (4x4 cm square), TKF50D (5cm round), TKF75D (7.5cm round), TKF4060V (4x6cm oval), TKF50100V (5x10cm oval), TKF4080 (4x8cm rectangle) and TKF50100 (5x10cm rectangle)
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 882.1320 Cutaneous electrode.
(a)
Identification. A cutaneous electrode is an electrode that is applied directly to a patient's skin either to record physiological signals (e.g., the electroencephalogram) or to apply electrical stimulation.(b)
Classification. Class II (performance standards).
0
510(k) Summary
AUG 0 8 2009
As Required by 21 section 807.92 ( c )
1-Submitter Name: Everyway Medical Instruments Co., Ltd 3 FL., No.5, LANE 155, Sec. 3, Peishen Rd 2-Address: Shen Keng Hsiang. 222 Taipei Hsien. Taiwan (ROC)
3-Phone:
l
(886) 2 2662 0038 (886) 2 2664 5566
4-Fax:
5-Contact Person: Mr Robert Tu (General Manager)
6-Date summary prepared: July 28, 2009
7 - Official Correspondent: Mansour Consulting LLC
8- Address: 845 Aronson Lake Court. Roswell, GA 30075 USA
9- Phone: 678-908-8180
10- Fax: 678-623-3765
11- Contact Person: Jay Mansour, President
12-Device Trade or Proprietary Name: Lifecare electrodes
13-Device Common or usual name: Lifecare Neurostimulation electrodes
14-Device Classification Name: Cutaneous electrode
15-Substantial Equivalency is claimed against the following device:
- · Lifecare electrodes from Everyway Medical
- Instruments Co., Ltd. 510k# K012463
· Gemore electrodes from Gemore Technology Co. Ltd, 510k#
16-Description of the Device:
The Lifecare electrodes are constructed with four basic components: a wire; an insulation backing, a conductive surface; and a conductive adhesive gel. The devices function by conducting an electrical signal from a neurostimulation device through the wire. The signal is then dispersed from the wire across the conductive surface. Finally the signal is transmitted from the conductive surface through the conductive adhesive gel to the surface of the patient's skin.
Everyway Self Adhesive Electrode, Wire series are non-sterile, disposable laminated, flexible structures composed of material commonly used in this application:
First Laver - White spun laced nonwoven tape or white thick Polyethylene foam or a polypropylene substrate, coated with biocompatible adhesive.
Second Laver - Conductive plastic film
Third Layer – Biocompatible conductive hydrogel coupling media
1
The electrodes are designed for single-patient/single application use. Because of the adhesive nature of the biocompatible hydrogel, no securing materials are required to secure the device to the patient's skin. The electrode has one type of connection point that can be used to connect the stimulation device the electrodes. This connection point is compatible with standard, marketed Neurostimulation devices.
For the electrical connection, Everyway provides one type of connection:
Wire Series - Lead wire assembly - 4.5" - 6" wire with 0.080 in. diameter female socket connected to one side of the wire.
These electrodes are: TKF5050 (5x5 cm square), TKF4040 (4x4 cm square), TKF50D (5cm round), TKF75D (7.5cm round), TKF4060V (4x6cm oval), TKF50100V (5x10cm oval), TKF4080 (4x8cm rectangle) and TKF50100 (5x10cm rectangle)
17-Intended use of the device: (refer to FDA form attached) The Lifecare electrodes are intended for use with transcutaneous neurostimulation devices as over the counter. Some common type of neurostimulation devices include, but are not limited to, TENS devices and EMS devices. Transcutaneous neurostimulation electrodes are passive devices serving as an interface between a patient's skin and a neurostimulation device.
18-Safetv and Effectiveness of the device:
This device is safe and effective as the predicate devices cited above as detailed within this submission.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three overlapping wings, representing the department's mission to protect and promote the health and well-being of Americans. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle.
Everyway Medical Instrument Co., Ltd. % Mansour Consulting LLC Mr. Jay Mansour 845 Aronson Lake Court Roswell, Georgia 30075
ood and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Public Health Service
AUG 03 2009
Re: K083302
Trade Name: Lifecare Electrodes Regulation Number: 21 CFR 882.1320 Regulation Name: Cutaneous Electrodes Regulatory Class: II Product Code: GXY Dated: June 22, 2009 Received: June 24, 2009
Dear Mr. Mansour:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
3
Page 2 - Mr. Jay Mansour
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH0ffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please : note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Mark N. Melkerson
Director Division of General, Restorative and Neurological Devices Office of Device Evaluation
Center for Devices and Radiological Health Radiological Health
Enclosure
4
Indications for Use
510(k) Number (if known): K083302
Device Name: Lifecare Electrodes
Indications For Use:
The Lifecare electrodes are intended for use with transcutaneous neurostimulation devices as . over the counter. Some common type of neurostimulation devices include, but are not limited to, TENS devices and EMS devices. Transcutaneous neurostimulation electrodes are passive devices serving as an interface between a patient's skin and a neurostimulation device.
Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence. of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off)
(Division Sinn-Off Division of Surgical, Orthopedic, and Restorative Devices
510(k) Number K083302
Page 1 of